Ocular Hypertension
📧 Sign up to get email alerts when something new happens for Ocular Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-04-02Clinical Trial Update: To Compare the Efficacy and Safety of Perrigo's Product to an FDA Approved Product for the Treatment of Glaucoma or Ocular Hypertension in Both Eyes [Phase 3]
Phase 3 trial comparing Perrigo's glaucoma/ocular hypertension product to an FDA-approved comparator has completed, and results have been po…
-
CLINICAL_TRIALS trial_result · 2025-03-27Clinical Trial Update: OPC-1085EL in the Treatment of Primary Open Angle Glaucoma or Ocular Hypertension in Chinese Subjects [Phase 3]
This document reports the completion of Phase 3 trials of OPC-1085EL for primary open-angle glaucoma and ocular hypertension in Chinese subj…
-
CLINICAL_TRIALS trial_result · 2025-03-26Clinical Trial Update: Comparison of Efficacy and Ocular Surface Assessment Between BRIDIN-plus and Combigan in Glaucoma or Ocular Hypertensive [Phase 4]
A completed Phase 4 clinical trial comparing BRIDIN-plus with Combigan for efficacy and ocular surface in patients with glaucoma or ocular h…
-
CLINICAL_TRIALS trial_result · 2025-03-21Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of OTX-TIC (Travoprost) Intracameral Implant for Patients With Open-angle Glaucoma (OAG) or Ocular Hypertension (OHT) [Phase 2]
Phase 2 study evaluating the efficacy and safety of the OTX-TIC travoprost intracameral implant for Open Angle Glaucoma or Ocular Hypertensi…
-
CLINICAL_TRIALS trial_result · 2025-03-07Clinical Trial Update: Comparative Study of the NIDEK TONOREF III with Predicate Devices [NA]
A completed comparative clinical trial evaluating the NIDEK TONOREF III tonometer against predicate devices for intraocular pressure measure…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-02-11Clinical Trial Update: Open-Label Study of Safety of H1337 in Healthy Volunteers [Phase 1]
Open-label Phase 1 safety study of H1337 in healthy volunteers completed; Open-angle glaucoma and ocular hypertension are listed as the stud…
-
CLINICAL_TRIALS trial_result · 2025-01-20Clinical Trial Update: Qlaris Phase 2 Study of QLS-111 in POAG And/or OHT Patients [Phase 2]
This notice reports the completion of a Phase 2 study evaluating QLS-111 in patients with primary open-angle glaucoma and ocular hypertensio…
-
CLINICAL_TRIALS trial_result · 2025-01-20Clinical Trial Update: A Study to Determine the Safety and Tolerability of 2 Concentrations of QLS-101 [Phase 2]
Phase 2 trial evaluating the safety and tolerability of two concentrations of QLS-101 in Sturge-Weber syndrome and glaucoma-related conditio…
-
CLINICAL_TRIALS trial_result · 2025-01-20Clinical Trial Update: Safety and Tolerability Study of QLS-101 in Adolescents With Sturge-Weber Syndrome (SWS)-Related Glaucoma Due to Elevated Episcleral Venous Pressure (EVP) [Phase 2]
A Phase 2 safety and tolerability study of QLS-101 in adolescents with Sturge-Weber syndrome-related glaucoma due to elevated episcleral ven…
-
CLINICAL_TRIALS trial_result · 2025-01-20Clinical Trial Update: Qlaris Study of QLS-111 in Combination With a PGA for OAG and/or OHT Patients [Phase 2]
Phase 2 clinical trial update for QLS-111 in combination with a prostaglandin analogue for open-angle glaucoma and ocular hypertension; the …
-
CLINICAL_TRIALS trial_result · 2025-01-17Clinical Trial Update: Study to Evaluate QLS-101 Compared to Timolol Maleate Eye Drops in Subjects With High Eye Pressure (Glaucoma or Ocular Hypertension). [Phase 2]
A Phase 2 trial comparing QLS-101 to Timolol Maleate Eye Drops in adults with high eye pressure due to primary open-angle glaucoma or ocular…
-
CLINICAL_TRIALS trial_result · 2024-11-06Clinical Trial Update: Dorzolamide+Timolol Multidose Preservative-free vs Dorzolamida+Timolol BAK Preserved Efficacy and Safety [Phase 4]
Phase 4 trial comparing preservative-free dorzolamide + timolol with preserved dorzolamide + timolol in open-angle glaucoma and ocular hyper…
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: EVALUATION of CATS TONOMETER PRISM in LASIK SUBJECTS
A completed clinical trial evaluating the CATS TONOMETER PRISM device in LASIK subjects with glaucoma, ocular hypertension, and normal tensi…
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Performance of the Travoprost Intraocular Implant [Phase 2]
Phase 2 trial results for the travoprost intraocular implant targeting open-angle glaucoma and ocular hypertension have been posted.
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: Effect of Latanoprost on Optic Nerve Perfusion [Phase 1]
Phase 1 study evaluating the effect of latanoprost on optic nerve perfusion has completed.
-
CLINICAL_TRIALS trial_result · 2024-10-01Clinical Trial Update: CLN-0045: Safety, and Efficacy of OTX-TIC in Participants With Open Angle Glaucoma or Ocular Hypertension [Phase 1]
This Phase 1 trial evaluated the safety and preliminary efficacy of OTX-TIC in participants with open-angle glaucoma or ocular hypertension,…
-
CLINICAL_TRIALS trial_result · 2024-07-18Clinical Trial Update: Efficacy and Safety Assessment of T4032 (Unpreserved Bimatoprost 0.01%) Versus Lumigan® 0.01% in Ocular Hypertensive or Glaucomatous Patients [Phase 3]
Phase 3 trial comparing T4032, unpreserved bimatoprost 0.01%, to Lumigan 0.01% in patients with ocular hypertension or glaucoma. The study h…
-
CLINICAL_TRIALS trial_result · 2024-07-15Clinical Trial Update: A Long Term Study of STN1012600 in Subjects With Open Angle Glaucoma or Ocular Hypertension [Phase 3]
The document reports that the long-term Phase 3 study of STN1012600 in open-angle glaucoma or ocular hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2024-05-28Clinical Trial Update: A Phase III Multinational Multicenter Investigator-Masked Randomized Active-Controlled Trial Comparing the Efficacy and Safety of DE-130A With Xalatan® in Patients With Open-Angle Glaucoma or Ocular Hypertension [Phase 3]
Phase III multinational, investigator-masked, active-controlled trial comparing DE-130A with Xalatan (latanoprost) in open-angle glaucoma or…
-
CLINICAL_TRIALS trial_result · 2024-05-10Clinical Trial Update: Comparison of Bimatoprost Sustained Release (SR) to Selective Laser Trabeculoplasty (SLT) in Adults With Open-Angle Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 trial comparing Bimatoprost Sustained Release (SR) with selective laser trabeculoplasty (SLT) in adults with open-angle glaucoma or …
-
CLINICAL_TRIALS trial_result · 2024-05-10Clinical Trial Update: Safety and Efficacy Study of JV-GL1 in Patients With Open-Angle Glaucoma or Ocular Hypertension [Phase 1, Phase 2]
Phase 1/2 safety and efficacy study of JV-GL1 in open-angle glaucoma or ocular hypertension has been suspended.
-
CLINICAL_TRIALS trial_result · 2024-04-29Clinical Trial Update: Intraocular Pressure in Ocular Hypertensives With Scleral Lens Wear [NA]
A Mayo Clinic study evaluating intraocular pressure in ocular hypertensives wearing scleral lenses has been terminated; results were posted …
-
CLINICAL_TRIALS trial_result · 2024-04-17Clinical Trial Update: Nebivolol 0.5, 1.0, or Timolol 0.5 Suspension Compared to Timolol 0.5 Solution to Treat Glaucoma/Ocular Hypertension [Phase 2]
Phase 2 trial comparing nebivolol and timolol suspensions to timolol solution for open-angle glaucoma and ocular hypertension; results poste…
-
CLINICAL_TRIALS trial_result · 2024-03-15Clinical Trial Update: A Phase III Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Compared With Latanoprost Ophthalmic Solution in Subjects With OAG or OHT [Phase 3]
A Phase III trial comparing DE-117 ophthalmic solution to latanoprost for safety and efficacy in open-angle glaucoma or ocular hypertension …
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: BREMEN Eye Drops Versus Combigan for Open-angle Glaucoma or Intraocular Hypertension [Phase 3]
Phase 3 trial comparing BREMEN Eye Drops to Combigan for ocular hypertension and primary open-angle glaucoma has completed.